Previous 10 | Next 10 |
ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. Growth stocks were pressured as the Federal Reserve turne...
Shares of DexCom (NASDAQ: DXCM) surged by 23.6% in March, according to data provided by S&P Global Market Intelligence . The rise has brought the diabetes management company's shares to nearly the same level as they were at the beginning of this year. Image source: G...
Report advances Dexcom’s environmental, social, and governance (ESG) transparency by providing new disclosures including company’s first Sustainability Accounting Standards Board (SASB) index DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time co...
DexCom (NASDAQ:DXCM) said the new Dexcom ONE continuous glucose monitoring (CGM) system will launch in U.K. in May. Dexcom ONE, a wearable sensor and transmitter, is a real-time CGM (rt-CGM) system that sends real-time values wirelessly to a compatible smart device. The company said...
On the heels of the latest NICE guidelines, Dexcom ONE is in review by NHS England for addition to the Drug Tariff DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today the new Dexcom ONE Contin...
Philippe Laffont’s 13F portfolio value decreased from $24.58B to $22.55B this quarter. They increased Tesla and Microsoft while reducing Moderna, Snowflake, DoorDash, Marqeta, and Twilio. They also added Pfizer, Visa, and Applied Materials while dropping UiPath. For f...
DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its first quarter 2022 financial results after market close on Thursday, April 28, 2022. Management will hold a conference call to review the company's first quarter 2022 performance starting at 4:30 p.m. (Eastern T...
DexCom Inc. (NASDAQ:DXCM) traded today at a new 52-week high of $510.91. This new high was reached on below average trading volume as 103,000 shares traded hands, while the average 30-day volume is approximately 3.3 million shares. DexCom Inc designs and commercializes continuous glucose...
DexCom (NASDAQ: DXCM) has revolutionized the lives of people suffering from diabetes. The company introduced the first real-time continuous glucose monitoring (CGM) system back in 2006, raising the standard of care for a generation of patients. DexCom's robust business performan...
Stock Market Today Mid-Morning Updates On Friday, the Dow Jones Industrial Average is up by 60 points. This comes as the U.S. and European Union (EU) announced a new partnership to reduce Europe’s reliance on Russian energy, the start of a years-long effort to further iso...
News, Short Squeeze, Breakout and More Instantly...
2024-07-04 10:00:00 ET Growth-oriented investors have experienced a bit of a roller-coaster ride over the past few years. Many companies in the "growth stock" category were struggling just two years ago, but in the bull market we are now experiencing, they're delivering very different resul...
DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its second quarter 2024 financial results after market close on Thursday, July 25, 2024. Management will hold a conference call to review the company's second quarter 2024 performance starting at 4:30 p.m. (Eastern Time) on the...